PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech Republic
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2100
https://www.valueinhealthjournal.com/article/S1098-3015(12)03814-4/fulltext
Title :
PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03814-4&doi=10.1016/j.jval.2012.08.2100
First page :
A419
Section Title :
Cancer
Open access? :
No
Section Order :
753